A detailed history of First Horizon Advisors, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 576 shares of BMRN stock, worth $38,557. This represents 0.0% of its overall portfolio holdings.

Number of Shares
576
Previous 576 -0.0%
Holding current value
$38,557
Previous $50,000 6.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$76.22 - $98.51 $10,975 - $14,185
144 Added 33.33%
576 $55,000
Q2 2023

Aug 03, 2023

SELL
$86.68 - $100.3 $6,847 - $7,923
-79 Reduced 15.46%
432 $37,000
Q4 2022

Feb 10, 2023

BUY
$80.93 - $108.63 $1,213 - $1,629
15 Added 3.02%
511 $52,000
Q3 2022

Nov 09, 2022

SELL
$82.16 - $96.94 $3,204 - $3,780
-39 Reduced 7.29%
496 $41,000
Q2 2022

Aug 02, 2022

BUY
$71.48 - $86.85 $34,810 - $42,295
487 Added 1014.58%
535 $44,000
Q1 2022

May 10, 2022

SELL
$74.28 - $92.69 $15,301 - $19,094
-206 Reduced 81.1%
48 $4,000
Q4 2021

Feb 09, 2022

BUY
$71.72 - $91.47 $143 - $182
2 Added 0.79%
254 $22,000
Q3 2021

Nov 15, 2021

BUY
$74.77 - $85.47 $12,860 - $14,700
172 Added 215.0%
252 $19,000
Q3 2021

Nov 09, 2021

SELL
$74.77 - $85.47 $43,441 - $49,658
-581 Reduced 87.9%
80 $6,000
Q2 2021

Aug 09, 2021

SELL
$75.51 - $84.79 $4,228 - $4,748
-56 Reduced 7.81%
661 $55,000
Q1 2021

May 11, 2021

BUY
$74.73 - $90.69 $4,558 - $5,532
61 Added 9.3%
717 $54,000
Q4 2020

Feb 11, 2021

BUY
$72.61 - $90.2 $14,812 - $18,400
204 Added 45.13%
656 $57,000
Q3 2020

Nov 12, 2020

BUY
$71.87 - $131.03 $4,312 - $7,861
60 Added 15.31%
452 $34,000
Q1 2020

May 05, 2020

BUY
$71.37 - $96.85 $4,210 - $5,714
59 Added 17.72%
392 $33,000
Q3 2019

Oct 23, 2019

BUY
$67.4 - $85.11 $20,354 - $25,703
302 Added 974.19%
333 $22,000
Q1 2019

Apr 26, 2019

BUY
$84.2 - $98.62 $2,610 - $3,057
31 New
31 $0
Q4 2018

Feb 11, 2019

SELL
$80.14 - $106.07 $560 - $742
-7 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$76.01 - $99.03 $532 - $693
7 New
7 $0

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.